Molecular Dynamics (MD) Simulation Software Market Analysis

Molecular Biology Simulation Software Market to Reach USD 1.8B by 2033 at 9.2% CAGR

MD simulation is the volume workhorse of the market, encompassing commercial products such as AMBER and GROMACS-based cloud wrappers, as well as Schrödinger's Desmond engine. Demand is tightly correlated with HPC allocation growth at academic computing clusters and biopharma discovery groups. GPU-accelerated MD on cloud infrastructure is compressing per-simulation cost but expanding the total number of simulation runs, sustaining revenue growth.